Millendo Announces Initiation of Phase 2b Clinical Trial of Nevanimibe in Patients with Classic CAH September 13, 2018
KalVista Pharmaceuticals Announces the Closing of its Public Offering of Common Stock and Full Exercise of the Underwriters’ Over-allotment Option to Purchase Additional Shares September 10, 2018
Verastem Oncology Announces Investigator Sponsored Study on Duvelisib in Combination with Venetoclax September 6, 2018
